Smart Necklace by Opter is What Forbes Calls ‘The New Must-Have in Wearable Tech,’ Launching on Indiegogo Oct. 3

Opter Pose tracks posture, UV, blue light, fitness, and sleep, and comes in the form of a stylish unisex necklace or clip. Press Release – updated: Sep 26, 2017 SAN FRANCISCO, September 26, 2017 (Newswire.com) – When Opter[1] launches on Indiegogo Oct. 3, consumers looking for a more functional wearable will finally have a fashionable alternative to the basic plastic...

READ MORE Smart Necklace by Opter is What Forbes Calls ‘The New Must-Have in Wearable Tech,’ Launching on Indiegogo Oct. 3

Nortel Networks Enhances OPTera Long Haul Portfolio; Raman Amplification Drives Reduced Costs for High Capacity Submarine Optical Backbones

HANOVER, Germany–(BUSINESS WIRE[1])–March 13, 2003–Nortel Networks (NYSE:NT)(TSX:NT) today announced new, customer driven enhancements to the Nortel Networks OPTera Long Haul portfolio for use in un-repeatered submarine applications.Extended, un-repeatered submarine links of up to 350 kilometers can now be achieved through Raman amplification, a network component that boosts the optical signal to achieve greater distances. This eliminates the need for costly...

READ MORE Nortel Networks Enhances OPTera Long Haul Portfolio; Raman Amplification Drives Reduced Costs for High Capacity Submarine Optical Backbones

Iovance Biotherapeutics Inc (IOVA-Q) Quote

PR Newswire – Tue Aug 20, 9:00AM CDT The “Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunotherapy” report has been added to ResearchAndMarkets.com’s offering. https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg This report includes: — An overview of Tumor Infiltrating Lymphocytes (TILs) for the treatment of metastatic cancer — Discussion of the development of TIL as a treatment option for melanoma and the possibilities to...

READ MORE Iovance Biotherapeutics Inc (IOVA-Q) Quote

Novartis Ag (NVS-N) Quote

GlobeNewswire – Mon Dec 21, 7:04AM CST Reportlinker.com announces the release of the report “Biosimilar Lymphocyte Modulator Global Market Report 2020-30: COVID-19 Growth and Change” – https://www.reportlinker.com/p05999216/?utm_source=GNW 21 billion in 2020 at a compound annual growth rate (CAGR) of -5.57%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote...

READ MORE Novartis Ag (NVS-N) Quote